Called Zmapp, the three companies say the drug was first identified in January of this year. According to Mapp's website, the Ebola drug is "a cocktail" of monoclonal antibodies which had previously been tested on monkeys.

In a joint statement, the companies said, "As such, very little of the drug is currently available. Any decision to use an experimental drug in a patient would be a decision made by the treating physician under the regulatory guidelines of the FDA. Mapp and its partners are cooperation with appropriate government agencies to increase production as quickly as possible."

Literally days before Dr. Brantly and Writebol were stricken with Ebola, Mapp published a news release announcing an exclusive, worldwide license to their drug. "This license," said Jeffrey Turner, President and CEO of Defyrus, "places our ZMAb technology in the hands of experienced antibody manufacturers with specific regulatory expertise and funding. We share a joint vision with LeafBio to deliver an effective treatment for Ebola virus infection on a cost effective basis globally."

According to a press release earlier this year, in March, the National Institutes of Health (NIH) awarded a five-year grant of up to $28 million to establish a new center for excellence to find the drug.

Erica Ollmann Saphire, a professor at Scripps Research Institute was quoted as saying the efforts are "a global collaboration."

For decades, the press release noted, scientists thought no antibodies were effective against the Ebola virus, but in 2012, research from the US Army Medical Research Institute of Infectious Diseases showed that a mix of antibodies can stop the virus. Other labs around the world were simultaneously testing other such antibody cocktails with success.

Antibodies are currently thought to be the best strategy for treating rare and deadly viruses such as Ebola because they are effective even a couple of days after exposure, a time period during which a person could be airlifted to a hospital for treatment.

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Hundreds Accept Jesus Christ in Poland at Franklin Graham Rally

Grammy-Winning Christian Artist Mandisa Has Died: Report

How You Can Send Letters of Encouragement to Jailed Pro-Life Heroes

'Americans Cannot Allow the Biden Administration to Sign Away Their Birthright': Congressmen Warn of WHO Pandemic Agreement

Illegal Immigrants Being Moved into Soldiers' Home Where Veterans Must Pay to Stay

House Democrats Vow to Codify 'Rights' to Trans Surgeries, Hormones, Puberty Blockers

18-Year-Old Female Trans Student Charged for Planning Two Maryland School Shootings, Manifesto Said She Wanted to Be 'Famous'

Israel Strikes Deep Inside Iran, Nuclear Facilities NOT Hit

An Important Message from Japan to the world about the WHO, Japan and the Next So-called 'Vaccine'

Rand Paul: Brave Marine Revealed that 15 US Agencies Knew COVID-19 Was Created in Lab in 2018; But They Kept It Secret from American Public (VIDEO)

Confirmed: Researchers Reveal COVID mRNA Vaccines Contain Component that Suppresses Immune Response and Stimulates Cancer Growth

Farmers, Truckers Warn California Emissions Mandates Will Cause 'Catastrophic' Supply Chain Crisis

Fed Court Overturns State Law Protecting Women's Sports from 'Transgender' Athletes

Furry Infestation: Middle School Students Walk Out in Protest after School Leaders Allow 'Furries' to Terrorize Them (VIDEO)

Biden's Education Secretary Vows to Shut Down the Largest Christian University in the US

US to Back Rafah Op in Exchange for Israel Dropping Major Iran Strike; Report

Schumer Succeeds in Killing Off Mayorkas Impeachment Trial before It Can Even Begin

California Town Tears Down Beloved Hillside Cross

Danielle Smith Again Defends Alberta's Coming Ban on Transgender Mutilation of Children

Detransitioners: We Were Pushed to Transition as Teens, Now We're 'Vindicated' By Study Showing Kids Grow Out of It